Convertible Bond Issuance Decision - Including Put and Call Options

AribioLab Co., Ltd. (formerly Cha Vaccine Research Institute) decides to issue convertible bonds.
Maximum issuance amount of 2 billion won (based on call option exercise limit); underwriter is Hanul P&I.
Bondholders are granted a put option (8% compound annual yield), exercisable quarterly from June 2027.
Company acquires a call option (8% compound annual yield) by paying 80 million won (4%) to underwriter.
Conversion terms and fund utilization purposes are not clearly disclosed in the filing.